Creative Planning
PARN

Creative Planning’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

Creative Planning’s Portfolio PARN Stock Details PARN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-5,500
Closed -$8K – 5132
2016
Q3 		$8K Buy
5,500
+3,500
+175% +$5.42K ﹤0.01% 3697
2016
Q2 		$3K Buy
+2,000
New +$3.68K ﹤0.01% 3971

Other funds holding PARN

BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Creative Planning's PARN Position: Q4 2016 in Review

Creative Planning sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q4 2016, closing a stake of 5,500 shares — an estimated $8K sold.

Creative Planning first reported a position in PARN in Q2 2016 and held it in 2 quarters. The position peaked at $8K in Q3 2016. 20 funds tracked by Wall St. Rank hold PARN as of Q4 2016.

  • Creative Planning reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q4 2016 after selling out during the quarter.
  • Creative Planning sold 5,500 Parnell Pharmaceuticals Holdings Ltd shares in Q4 2016, an estimated $8K.
  • Creative Planning first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q2 2016 and held it in 2 quarters.
  • Creative Planning's Parnell Pharmaceuticals Holdings Ltd position peaked at $8K in Q3 2016.
  • 20 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q4 2016.

Based on Creative Planning's 13F filing for Q4 2016, filed 9 Jan 2017.